Treace Medical Concepts, Inc. TMCI 深 沪
等待开盘 10-07 09:30:00 美东时间
4.16
-0.320
-7.14%
华盛通- 最 高5.01
- 今 开4.53
- 成交量 16.11万股
- 最 低 4.0917
- 昨 收 4.48
- 总市值 23.00万
- 52周最高 7.08
- 市盈率 静 --
- 换手率 291.35%
- 52周最低 1.17
- 委 比 33.23%
- 总股本 5.53万
- 历史最高 37.17
- 量 比 1.37
- 振 幅 20.50%
- 历史最低 1.10
- 每 手 1
- 风险率 1.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Treace Medical Concepts Raises FY2026 Sales Guidance from $200.000M-$212.000M to $202.000M-$212.000M vs $205.920M Est
Treace Medical Concepts (NASDAQ:TMCI) raises FY2026 sales outlook from $200.000 million-$212.000 million to $202.000 million-$212.000 million vs $205.920 million estimate.
05-08 19:07
US Stocks Mixed; Dow Falls Over 100 Points
US stocks mixed; Dow falls 0.29% as inflation rate surges to 3.3%. Materials up 0.8%, financials down 0.8%. Asian markets close higher.
04-10 22:54
Treace Medical Concepts's Earnings: A Preview
Treace Medical Concepts (NASDAQ:TMCI) is gearing up to announce its quarterly e...
02-27 00:01
Treace Medical Concepts Completes First Case Utilizing Its Lapiplasty Lightning Technology
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced
01-09 05:09
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
Treace Medical Concepts filed a patent infringement lawsuit against Zimmer Biomet and Paragon 28, alleging violation of four patents related to its Lapiplasty® technology. The company, a leader in bunion correction systems, seeks injunctive relief and damages to protect its innovative research and technology. Treace holds 80 U.S. patents, 26 international patents, and has over 150 pending applications.
2025-06-05 17:00
Treace Medical Concepts To Showcase New Product Innovations And Present Interim Data From ALIGN3D And Mini3D Lapiplasty Clinical Studies At AOFAS Annual Meeting 2024 In Vancouver
Several current and next-generation technologies will be highlighted at Treace's booth and in surgeon training events at the AOFAS conference, including:Nanoplasty™ MIS 3D Osteotomy System: Nanoplasty™
2024-09-11 20:02
